NEW YORK, Nov. 16, 2024 /PRNewswire/ -- Experts from NYU Langone Heart will present the latest advancements in cardiovascular ...

Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

Amidst discrepant SPRINT and ACCORD data, this study confirms the benefits seen in nondiabetics, Shawna Nesbitt says.

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...

Niyondiko, N. (2024) Clinical Management of Diabetic Ketoacidosis in Pregnancy: A Review of Current Literature. Open Access Library Journal, 11, 1-25. doi: 10.4236/oalib.1112246 .

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

AI in healthcare is causing a revolution in how clinicians document, analyze, and make decisions. Two key breakthroughs ...

By providing a complete, timely view of the de-identified patient journey, including more than 5 billion clinical notes, nearly 100 million medical ... and benchmarking against ADHERE and GWTG-HF (Get ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

1 Improving the understanding of risk can allow clinicians to better personalize treatment approaches or catch HCC early ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

This summary highlights key health-related news. It includes a Chinese study advocating for region-specific diets to combat ...